See Service Details

Invetech, specialists in product development and custom automation for the medical, industrial and consumer markets, announces that TearLab Corporation's revolutionary TearLab Osmolarity System has been recognised for its innovative design with a prestigious Medical Design Excellence Award (MDEA).

TearLab Corporation retained Invetech to assist with the development and industrial design of its instrumentation. The TearLab Osmolarity system is the first technology that can quantitatively and objectively measure Dry Eye Disease in a doctor's office in seconds. Dry Eye Disease is a chronic and progressive condition that if left untreated can lead to serious eye damage.

The TearLab Osmolarity product won the award for its breakthrough design that significantly reduced the complexity, cost and patient discomfort of conventional tear testing technologies.

Eric Donsky, CEO of TearLab Corporation commented, "We are thrilled that our very first product has been recognised with the MDEA accolade. We are already seeing doctors and users gettingexcited about using the product frequently due to the reliable, accurate and simple nature of itsdesign. We very much appreciate Invetech's role in helping us develop a great product. Invetech delivered breakthrough thinking and world-class engineering, which is what you need to develop revolutionary products. We hope the technology platform we have created in conjunction with our partners, Invetech and MiniFab, will go on to be used in a range of other applications and other products in the near future."

TearLab was designed to achieve CLIA waiver status reflecting its focus on ease of use and consideration for the needs of both the patient and the clinician.The patented approach includes a range of new innovations including a hand-held pen system which operates from as little as 50 nanolitres of tear samples, considerably less than current swab methods. The pen is a smart collection device ergonomically designed to minimize patient discomfort, avoid sample dilution from reflex tearing and minimise sample evaporation, providing repeatable, accurate test results. It houses miniaturized electronics and holds a high vaue, disposable lab-on-a-chip a joint development between TearLab Corporation and MiniFab, specialists in the development and manufacture of advanced polymer microfluidics for disposable diagnostics. A desktop reader converts the results generated from the pen in to a quantitative measurement which is then displayed to the user. The entire process from tear collection to results now takes just seconds providing an eye care practitioner the opportunity to see more patients while improving the quality of care.